THE ECONOMIC IMPACT OF ADDING CEFTAROLINE FOSAMIL TO HOSPITAL FORMULARY FOR COMMUNITY ACQUIRED BACTERIAL PNEUMONIA: A HOSPITAL BUDGET IMPACT ANALYSIS IN THE UNITED STATES

被引：0
|
作者：
Huang, X. Y. [1 ]
Lodise, T. [2 ]
Friedland, D. [3 ]
Beresford, E. J. [1 ]
机构：
[1] Forest Res Inst Inc, Jersey City, NJ USA
[2] Albany Coll Pharm & Hlth Sci, Albany, NY USA
[3] Cerexa Inc, Oakland, CA USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A238 / A238
页数：1
相关论文
共 50 条
  • [31] Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials
    Shorr, Andrew F.
    Kollef, Mann
    Eckburg, Paul B.
    Llorens, Lily
    Friedland, H. David
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 75 (03) : 298 - 303
  • [32] COSTS-CONSEQUENCES ANALYSIS OF CEFTAROLINE FOSAMIL FOR THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
    Salgado, De Santana C.
    Holanda, P.
    Senna, T.
    Carmo, L.
    Alexandre, R. F.
    VALUE IN HEALTH, 2021, 24 : S109 - S109
  • [33] Impact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients
    Putot, A.
    Tetu, J.
    Perrin, S.
    Bailly, H.
    Piroth, L.
    Besancenot, J. -F.
    Bonnotte, B.
    Chavanet, P.
    d'Athis, P.
    Charles, P. -E.
    Sordet-Guepet, H.
    Manckoundia, P.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2016, 35 (03) : 489 - 495
  • [34] Impact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients
    A. Putot
    J. Tetu
    S. Perrin
    H. Bailly
    L. Piroth
    J.-F. Besancenot
    B. Bonnotte
    P. Chavanet
    P. d’Athis
    P.-E. Charles
    H. Sordet-Guépet
    P. Manckoundia
    European Journal of Clinical Microbiology & Infectious Diseases, 2016, 35 : 489 - 495
  • [35] Impact of antibiotic changes on hospital stay and treatment duration in community-acquired pneumonia
    Ryu, Jiwon
    Kim, Nak-Hyun
    Ohn, Jung Hun
    Lim, Yejee
    Lee, Jongchan
    Kim, Hye Won
    Kim, Sun-wook
    Park, Hee-Sun
    Kim, Eu Suk
    Yoon, Seonghae
    Heo, Eunjeong
    Kim, Eun Sun
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [36] The Impact of Drug Interactions in Patients with Community-Acquired Pneumonia on Hospital Length of Stay
    Schmitt, Johannes Peter
    Kirfel, Andrea
    Schmitz, Marie-Therese
    Kohlhof, Hendrik
    Weisbarth, Tobias
    Wittmann, Maria
    GERIATRICS, 2022, 7 (01)
  • [37] A BUDGET IMPACT AND RETURN ON INVESTMENT ANALYSIS OF INCORPORATING DRUG - ELUTING STENTS INTO A CHINESE HOSPITAL MEDICAL DEVICE FORMULARY - A HOSPITAL PERSPECTIVE
    Tan, B.
    Fu, Y.
    Lu, Y.
    Ren, M.
    Song, Y.
    Liu, X.
    Xuan, J.
    VALUE IN HEALTH, 2020, 23 : S189 - S190
  • [38] HOSPITAL ACQUIRED PNEUMONIA: 1 YEAR FOLLOW AUDIT TO ASSESS IMPACT OF HOSPITAL ACQUIRED PNEUMONIA PREVENTION CARE BUNDLE
    Chee, E.
    Bright, C.
    Leahy, D.
    Linnane, S.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (SUPPL 1) : S28 - S28
  • [39] The Role of Delafloxacin in Patients with Community-Acquired Bacterial Pneumonia in the Outpatient Setting: A Budget Impact Model
    Thomas P. Lodise
    Glenn S. Tillotson
    Andrew Spargo
    Duygu Bozkaya
    Jill Massey
    Clinical Drug Investigation, 2020, 40 : 961 - 971
  • [40] The Role of Delafloxacin in Patients with Community-Acquired Bacterial Pneumonia in the Outpatient Setting: A Budget Impact Model
    Lodise, Thomas P.
    Tillotson, Glenn S.
    Spargo, Andrew
    Bozkaya, Duygu
    Massey, Jill
    CLINICAL DRUG INVESTIGATION, 2020, 40 (10) : 961 - 971
12345